HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baskin, F. Articles by Cullum, C. M. Search for Related Content PubMed PubMed Citation Articles by Baskin, F. Articles by Cullum, C. M.

Platelet APP isoform ratios correlate with declining cognition in AD

From the Departments of Neurology (Drs. Baskin, Rosenbreg, and Iyer), Academic Computing Services (Dr. Hynan), and Psychiatry (Dr. Cullum), University of Texas Southwestern Medical Center, Dallas.

Address correspondence and reprint request to Dr. F. Baskin, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9036; e-mail: Fbaski{at}mednet.swmed.edu

BACKGROUND: Platelets and neurons both contain large quantities of two carboxyl-truncated 120 to 130 and 110 kDa Alzheimer amyloid precursor proteins (APPs). Platelets taken from patients with AD have been reported to contain a reduced ratio of these APPs.

OBJECTIVE: To further study the AD specificity of reduced platelet APP ratios and to determine whether, after 3 years, cognitive losses in AD are accompanied by similarly reduced platelet APP ratios.

METHODS: To test the AD specificity of reduced platelet APP ratios, we quantitated these APPs in eight patients with PD and six patients with hemorrhagic stroke (HS). To determine whether further cognitive losses correlate with platelet APP ratio reductions in patients with AD, the authors re-examined platelet APPs and Mini-Mental State Examination (MMSE) scores of 10 patients with AD and 11 controls, who were tested 3 years ago. APP ratios were determined by the average of six assays using Western blotting with m22C11 monoclonal antibody, enhanced chemoluminescence, and digital scanning of autoradiographs.

RESULTS: APP ratios were normal in the patients with PD and HS, further supporting the AD specificity of this assay. After 3 years, the MMSE scores and APP ratios of our control subjects changed by <4%. However, the average MMSE scores of our patients with AD declined from 16.4 to 8.3, and their average 120 to 130/110 kDa APP ratios declined from 5.8 to 3.6. The difference between AD and control APP ratios, with no overlap, is significant and the correlation between the 3-year decline in AD MMSE scores and reduced APP ratios (r = 0.69) was significant.

CONCLUSIONS: Although the number of subjects analyzed was limited, reduced platelet APP ratios appear to be a specific biological marker of AD and a biological index of the severity of cognitive loss in AD.

Key words: Mini-Mental State Examination—Alzheimer amyloid precursor protein—Platelets.

This article has been cited by other articles:

				F. Colciaghi, E. Marcello, B. Borroni, M. Zimmermann, C. Caltagirone, F. Cattabeni, A. Padovani, and M. Di Luca Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease Neurology, February 10, 2004; 62(3): 498 - 501. [Abstract] [Full Text] [PDF]

				B. Borroni, F. Colciaghi, C. Caltagirone, L. Rozzini, L. Broglio, F. Cattabeni, M. Di Luca, and A. Padovani Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type: A 2-Year Follow-up Study Arch Neurol, December 1, 2003; 60(12): 1740 - 1744. [Abstract] [Full Text] [PDF]

				F. Baskin, R. N. Rosenberg, X. Fang, L. S. Hynan, C. B. Moore, M. Weiner, and G. L. Vega Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients Neurology, June 24, 2003; 60(12): 2006 - 2007. [Abstract] [Full Text] [PDF]

				H. Hattori, M. Matsumoto, K. Iwai, H. Tsuchiya, E. Miyauchi, M. Takasaki, K. Kamino, J. Munehira, Y. Kimura, K. Kawanishi, et al. The {tau} Protein of Oral Epithelium Increases in Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M64 - 70. [Abstract] [Full Text] [PDF]

				A. Padovani, B. Borroni, F. Colciaghi, C. Pettenati, E. Cottini, C. Agosti, G. L. Lenzi, C. Caltagirone, M. Trabucchi, F. Cattabeni, et al. Abnormalities in the Pattern of Platelet Amyloid Precursor Protein Forms in Patients With Mild Cognitive Impairment and Alzheimer Disease Arch Neurol, January 1, 2002; 59(1): 71 - 75. [Abstract] [Full Text] [PDF]

				A. Padovani, L. Pastorino, B. Borroni, F. Colciaghi, L. Rozzini, R. Monastero, J. Perez, C. Pettenati, M. Mussi, G. Parrinello, et al. Amyloid precursor protein in platelets: A peripheral marker for the diagnosis of sporadic AD Neurology, December 26, 2001; 57(12): 2243 - 2248. [Abstract] [Full Text] [PDF]

				R. Diaz-Arrastia and F. Baskin New Biochemical Markers in Alzheimer Disease Arch Neurol, March 1, 2001; 58(3): 354 - 356. [Full Text] [PDF]

				B. Borroni, F. Colciaghi, L. Pastorino, C. Pettenati, E. Cottini, L. Rozzini, R. Monastero, G. L. Lenzi, F. Cattabeni, M. Di Luca, et al. Amyloid Precursor Protein in Platelets of Patients With Alzheimer Disease: Effect of Acetylcholinesterase Inhibitor Treatment Arch Neurol, March 1, 2001; 58(3): 442 - 446. [Abstract] [Full Text] [PDF]